Over the last decade, the interest in transcranial direct current stimulation (tDCS) has continued to increase, along with consideration of how it affects neuroplasticity mechanisms in the brain. Both human and animal studies have demonstrated numerous benefits and, although its application has increased, the neurophysiological mechanisms underlying tDCS' beneficial effects remain largely unknown. Recent studies have shown that long-term potentiation (LTP) increases following tDCS. In this work, we utilized a rodent model of tDCS to directly assess changes in the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor, a critical protein for enhancing synaptic transmission. Animals were subjected to 250 μA of direct current (DC) stimulation for 30 min with immediate tissue collection. Translocation and phosphorylation of AMPA receptors were examined using protein immunoblot analysis following a subcellular fractionation method. Our findings show that a single application of in vivo tDCS can affect both the translocation and phosphorylation of AMPA receptors in the hippocampus while increasing AMPA receptor phosphorylation in the hypothalamus. In the hippocampus, tDCS increased AMPA translocation to the synapse and increased the phosphorylation of the S831 site on GluA1. In the hypothalamus, no statistically significant changes were observed in AMPA translocation while an increase in the phosphorylation of the S831 site was observed. No changes in the phosphorylation of GluA1 at the S845 site were detected in either brain region. In sum, our findings identify specific AMPA receptor changes induced by tDCS, thereby providing further details on the mechanisms by which tDCS could affect the establishment of LTP and modulate neuroplasticity.
Introduction
The use of transcranial direct current stimulation (tDCS) as a clinical tool is becoming more widely used based on its beneficial effects. For instance, tDCS has been shown to mitigate deficits seen with many neurological diseases including increasing motor function and partial cognitive recovery in Parkinson's disease (Broeder et al., 2015) , modulating brain activity in stroke patients (Fregni et al., 2005) , and improving working memory performance in Alzheimer's disease patients (Marceglia et al., 2016) . Moreover, tDCS has been shown to augment performance in cognitive and motor tasks such as skill acquisition in threat detection (Parasuraman & McKinley, 2014) , modulate procedural learning on a serial reaction time task (Ferrucci et al., 2013) , and increase long-term memory formation on a ballistic movement task (Rroji, van Kuyck, Nuttin, & Wenderoth, 2015) . Given its effectiveness in augmenting performance in such tasks, noninvasive brain stimulation would be an extremely valuable tool for training, potentially enhancing skill acquisition and reducing training time.
The concept of electrical stimulation modulating neuronal activity has been a topic of study in the scientific community for decades (Esmaeilpour et al., 2017) . In 1956, a study showed that applying a current below action potential threshold to an active neuron modulated its firing frequency (Terzuolo & Bullock, 1956) . Several years later, it was shown that a polarizing direct current applied to the brain caused a change in neuronal firing rate for several hours after stimulation (Bindman, Lippold, & Redfearn, 1962) . These early efforts led to more recent investigations of polarity specificity, current intensity, stimulation duration, and electrode placement effects Kronberg, Bridi, Abel, Bikson, & Parra, 2017; Nitsche & Paulus, 2000) . Interestingly, the effects of tDCS persisted beyond the time of application with prolonged neuronal excitability changes observed 90 min after stimulation, measured by motor-evoked potential amplitudes (Nitsche & Paulus, 2001) . Taken together, the ability to acutely modulate neuronal firing in addition to its persistent effects suggests that tDCS could be modulating synaptic plasticity.
The N-Methyl-D-Aspartate (NMDA)-dependent LTP pathway is regulated through ionotropic glutamate receptors (Bliss & Collingridge, 2013) . The activation of NMDA receptors results in the modulation of α-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid (AMPA) receptors, which must be trafficked to the postsynaptic membrane and phosphorylated in order for LTP to occur (Bliss & Collingridge, 2013) . Two serine residues (S831 and S845) on the GluA1 subunit of AMPA receptors are particularly important for LTP occurrence. For instance, knock-in mice with non-functional S831 and S845 have shown decreased levels of LTP and hindered spatial memory retention in a hidden platform Morris water maze experiment wherein recollection was tested after learning (Lee et al., 2003) . Also, selectively inhibiting sodium and calcium channels significantly diminished tDCS-induced effects on LTP, suggesting the importance of these channels in modulating NMDA-dependent LTP pathways (Rohan, Carhuatanta, McInturf, Miklasevich, & Jankord, 2015; Stagg & Nitsche, 2011) . Our group showed that in vivo tDCS followed by ex vivo LTP induction in hippocampal slices increased field excitatory postsynaptic potentials (fEPSPs) when compared to LTP induction in hippocampal slices obtained from sham-treated rats. This effect was abolished by the administration of NMDA antagonists (Rohan et al., 2015) . Therefore, tDCS is altering LTP mechanisms that are involved in synaptic plasticity, indicative of its role in modulating memory and learning events. Based on the aforementioned studies, we hypothesized that tDCS could be altering synaptic plasticity associated with AMPA receptors in a way similar to the previously reported changes in NMDA-dependent longterm potentiation (LTP).
Our study aimed to address the hypothesis that a single bout of tDCS is capable of eliciting changes in AMPA receptor distribution and phosphorylation, according to its role in NMDA-related LTP processes. We assessed changes in the protein levels of AMPA receptor and its phosphorylated epitopes (S831 and S845) using subfractionation method to collect cytosolic and synaptoneurosome samples of hippocampal and hypothalamic brain areas of rats submitted to either sham or tDCS stimulation for 30 min. Our findings contribute toward a greater understanding of neurobiological mechanisms underlying the effects of noninvasive brain stimulation.
Methods

Animals
All animals (n = 8/group) used in this experiment were adult, male, Sprague Dawley rats (200-400 g) purchased from Charles River. Rats were quarantined for up to 10 days before surgical implantation of electrode casing and were housed in shoebox style cages with access to water and food ad libitum. Animals were handled daily (Monday-Friday) by qualified technicians. All experiments and handling procedures were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Air Force Research Laboratory Institutional Animal Care and Use Committee.
Surgery and electrode casing implantation
Animals were anesthetized with 5% isoflurane and 3% oxygen flow rate until appropriate level of sedation was reached and maintained at 1-2% isoflurane and 3% oxygen flow rate during surgery. A 25-mm 2 square electrode casing was secured to the skull (vet bond) immediately caudal to bregma (Fig. 1A) . Dental cement was applied around the outside of the casing and along the opening of the skin to allow for complete closure of the surgical area. Animals were allowed one week for recovery with daily assessments of body weight changes, physical signs of distress, electrode casing movement and/or bleeding from the electrode cap.
Acute transcranial electric current stimulation
Immediately prior to stimulation, the animals were weighed and examined for electrode casing shifts. Animals were attached with a cranial stimulating electrode (anode) and a ventral reference electrode (cathode) and placed in an open field chamber (45 × 40 cm with white walls). Stimulated animals were subjected to 250 μA for 30 min using a DC-stimulator (NeuroConn) box. Sham animals had the same electrode set up and were also placed in the open field arena but were not connected to the DC stimulator. All animals were awake, freely moving and were monitored by a technician. All animals were euthanized immediately following stimulation. Brains were dissected into whole hippocampus, hypothalamus, cortex regions and immediately frozen on dry ice for biochemical analysis.
Tissue preparation
Whole hippocampal tissue sample from each subject was prepared following the Syn-PER protein extraction method described by the manufacturer (ThermoFisher Scientific, Waltham, MA, USA), which yielded two protein fractions: a cytosolic and synaptosome (synaptic) fraction (Fig. 1B) . The synaptic (synaptosome) proteins are located in the postsynaptic density (PSD) or synaptic membrane. Protein concentration was assessed for each sample in duplicates, using the bicinchoninic acid assay (BCA, ThermoFisher Scientific, Waltham, MA, USA) according to manufacturer's instructions.
Protein blotting procedure
Following extraction and concentration determination, 8 µg of proteins for each sample were loaded on a 4-20% polyacrylamide gel SDS-PAGE. After electrophoresis, the proteins were transferred onto a nitrocellulose membrane and blocked for 1 h in a 5% bovine serum albumin phosphate buffered saline Tween solution (BSA-PBST). The membrane was then incubated overnight with primary antibodies targeting C-terminal (rabbit, 1:20,000; Abcam, Cambridge, MA, USA) or phosphorylated epitopes serine 831 (rabbit, 1:20,000; Abcam, Cambridge, MA, USA), serine 845 (rabbit, 1:1000; Abcam, Cambridge, MA, USA) and β-actin (rabbit, 1:40,000; EMD Millipore, Temecula, CA, USA) overnight at 4°C. No cross or co-incubation occurred between any primary antibodies on membranes. The following day, following washes with PBST, the membrane was incubated at room temperature with secondary antibody (goat anti-rabbit 1:15,000, Invitrogen, Waltham, MA, USA) for 1 h, washed and then visualized using enhanced chemiluminescence (SuperSignal West Femto, ThermoFisher Scientific, Waltham, MA, USA). Protein immunoblots were analyzed and quantified using ImageJ software using optical density measurements and appropriate correction for background.
Statistical analysis
All statistical analyses were completed using SigmaPlot (version 4.17). Two-way ANOVA, followed by Fisher's Least Significant Difference (FLSD) post hoc analysis, and two-tailed student t-tests were performed with a significant p-value of < 0.05. Graphs were generated using Graph Pad Prism 5.01 (La Jolla, CA). Values are expressed as mean ± SEM.
Results
To determine whether tDCS had an effect on GluA1 containing AMPA receptors, protein immunoblots were probed with specific antibodies targeting C-terminal and phosphorylation epitopes (S831 and S845) using samples from both hippocampal and hypothalamic cytosolic and synaptic subcellular fractions.
Analysis of hippocampal cytosolic and synaptic subcellular fractions
The first site assessed was the C-terminal end of the GluA1 subunit on the AMPA receptor. Analysis of the cytosolic subcellular fraction shows a significant difference in the total amount of GluA1 containing AMPA receptors with reduced levels in the stimulated cytosolic subcellular fraction when compared to sham group (OD values: sham = 0.67 ± 0.10 versus stimulated = 0.36 ± 0.04, p = .02, Fig. 2A ). Conversely, when the synaptic subcellular fraction was analyzed, the tDCS treated group had significantly more GluA1 containing AMPA receptors than the non-tDCS treated samples (sham = 1.48 ± 0.07 versus stimulated = 2.39 ± 0.16, p < .001; Fig. 2B ).
Next, we investigated tDCS-induced changes in the phosphorylation site S831 of AMPA in both the cytosolic and synaptic subcellular fractions. No changes were observed in the phosphorylation state of cytosolic samples between sham and stimulated samples (sham = 0.38 ± 0.06 versus stimulated = 0.36 ± 0.06, p = .57, Fig. 3A ). We observed a significant increase of phosphorylation at the S831 site in the synaptic subcellular fraction within the tDCS treated group relative to the sham group (sham = 1.02 ± 0.06 versus stimulated = 1.23 ± 0.04, p = .01, Fig. 3B ), however no significant changes were observed in the S845 epitope phosphorylation in cytosolic fraction (sham = 0.07 ± 0.03 versus stimulated = 0.06 ± 0.03, p = .86, Fig. 3C ). Likewise, there was no significant difference between sham and stimulated samples in the synaptic fraction (sham = 0.36 ± 0.03 versus stimulated = 0.36 ± 0.03, p = .94; Fig. 3D ). Overall, our findings of changes in AMPA receptor location (C-terminal of the GluA1 subunit) and phosphorylation (S831 site on the GluA1 subunit) between tDCS treated and non-tDCS treated samples highlight the stimulation-mediated modulation of AMPA receptors in the hippocampus.
Analysis of hypothalamic cytosolic and synaptic subcellular fractions
In order to examine whether tDCS is capable of exerting global effects on the brain, we investigated tDCS-induced changes in the hypothalamic levels of the same targets described above. Cytosolic fractions for stimulated and sham samples are not shown due to low levels of detection obtained within the antibody concentrations used in this experiment.
When investigating the levels of C-terminal AMPA receptors, no significant differences were observed in the synaptic subcellular sham or stimulated samples (sham = 0.02 ± 0.09 versus stimulated = 0.11 ± 0.07, p = .22; Fig. 4A ). Interestingly, there was a significant difference in the levels of phosphorylated S831 site between sham and stimulated synaptic samples (sham 0.68 ± 0.05 versus stimulated 0.92 ± 0.17, p < .004; Fig. 4B ). However, analysis of the S845 phosphorylation site in the synaptic subcellular hypothalamic AMPA receptor samples showed no significant difference between sham and stimulated groups (sham = 0.35 ± 0.07 versus stimulated = 0.43 ± 0.09, p = .35; Fig. 4C ). Taken together, these findings suggest that in vivo tDCS was effective in modulating the phosphorylation of the S831 epitope present in AMPA receptors from hypothalamic samples. 
Discussion
Our findings demonstrate that a single, 30-min application of tDCS can induce translocation and phosphorylation of hippocampal AMPA receptors. Increased phosphorylation of the S831 epitope was also observed in hypothalamic samples. The ability of tDCS to affect AMPA reception translocation and phosphorylation provides a mechanism by which electrical current can modulate neuronal processes relevant for synaptic plasticity. This work furthers previous observations by defining a role for AMPA receptors in the enhancement of neuroplasticity following tDCS.
Translocation of AMPA receptors in the hippocampus
We chose to target the GluA1 specific C-terminal due to the integral role of this subunit in increasing the synaptic response in hippocampal neurons during LTP in the CA3-CA1 Schaffer collateral pathway (Zamanillo et al., 1999) . In agreement with our laboratory's previous report showing tDCS-mediated increases in LTP (Rohan et al., 2015) , this study showed the translocation of GluA1-containing AMPA receptors from the cytosol to the synaptic membrane following a single bout of brain stimulation (Figs. 1B and 2 ). The reported translocation of AMPA receptors is similar to the neuroplasticity event seen during NMDA-dependent LTP when AMPA receptors are trafficked from surrounding perisynaptic locations to the postsynaptic membrane, resulting in increased synaptic strength (Makino & Malinow, 2009 ). Therefore, a mechanism by which tDCS could be eliciting its neurobiological effects on cognitive function could be via trafficking of AMPA receptors to the synaptic interface, leading to increased synaptic strength and plasticity. Importantly, our results were obtained in absence of any ex vivo treatment such as high frequency stimulation, as previously described (Kronberg et al., 2017; Rohan et al., 2015) .
Phosphorylation of AMPA receptors in the hippocampus
Along with translocation of AMPA receptors, receptor phosphorylation impacts LTP. For instance, lack of functional phosphorylation at S831 on the GluA1 subunit results in decreased AMPA conductance whereas dysfunction at the S845 site on the GluA1 subunit decreased the open probability of the receptor and impairs the capacity to maintain an open conformation (Lee, Takamiya, He, Song, & Huganir, 2010; Lee et al., 2003) . Accordingly, we observed increased phosphorylation in the S831 site following tDCS treatment, corroborating its involvement in the downstream effects in the NMDA-dependent LTP pathway (Henley, Barker, & Glebov, 2011) . The S831 phosphorylation site is of particular importance during the induction phase of LTP (Lee et al., 2010) and it has been associated with changes in channel conductance in the AMPA receptor, exerting a robust effect on AMPA receptor trafficking and insertion (Hayashi et al., 2000) .
Despite increased phosphorylation of the S831 site, our findings did not show changes in the S845 phosphorylation site in either hippocampal or hypothalamic samples. This could be due to the timing of sample collection. As described above, the S831 phosphorylation site is more prominently associated with the early induction phase of LTP.
The S845 site on GluA1 subunits has been suggested to prime the AMPA receptors for translocation (Derkach, Oh, Guire, & Soderling, 2007) , and due to the 30 min stimulation, a robust change in S845 phosphorylation would not have been observed. Another possibility is that S831 and S845 phosphorylation sites have been described to be differentially regulated by protein kinases A & C (Esteban et al., 2003) and CaMKII (Barria, Muller, Derkach, Griffith, & Soderling, 1997) , respectively, it is suggested that tDCS may facilitate specific intracellular signaling events such as protein kinase C and/or CaMKII activation. These assumptions require further investigating with assessments of both additional time points and molecular targets following acute brain stimulation.
Nonetheless, phosphorylation of the S831 epitope shown in this study as a result of a single, 30-min stimulation bout in vivo shows that S831 is affected by tDCS treatment and it is causing LTP-like downstream effects to occur. These effects are at least partially involved in the regulation of neuroplasticity events during LTP induction and receptor conductance in hippocampal neurons (Lee, 2006) .
No translocation of AMPA receptors in the hypothalamus
There was also no significant change in the hypothalamic translocation of the AMPA receptor (Fig. 4A) . As previously stated, one of the chief mechanisms associated with memory and learning processes in the hippocampus is the induction of LTP through the NMDA-dependent pathway, resulting in modulation of AMPA receptors (Luscher & Malenka, 2012) . The reason for observing a significant change in translocation of AMPA receptors in the hippocampus and not the hypothalamus may be due to its closer positioning relative to the electrode placement. The hypothalamus is ventrally located from the anodal head electrode that was placed on the dorsal aspect of the rodent's skull. Several factors such as electrode size, placement, and current intensity can affect the current density applied, affecting different regions of the brain. Due to the anisotropic properties of the brain and high variability of neuronal connectivity from subject to subject along with the shunting effects of the skull, it is extremely challenging to predict the pattern of electrical stimulation tDCS will exert on brain structures further away from the electrode (Faria, Hallett, & Miranda, 2011) . Therefore, it is possible that the threshold for translocation of AMPA receptors in the hypothalamus was simply not reached due to the distance from the electrode.
Another possibility would be that translocation of AMPA receptors in the hypothalamus is working through a different mechanism than in the hippocampus. Previous studies have shown that some NMDA containing neurons in the hypothalamus lack the NR2B subunit, which is crucial for the NMDA-dependent LTP process (Aubry, Bartanusz, Pagliusi, Schulz, & Kiss, 1995) . When the NR2B subunit was knocked down in mice, LTP induction was blocked, suggesting that this subunit plays a crucial role in LTP induction and synaptic plasticity. This is likely due to the interaction of the intracellular C-terminal tail on the NR2B subunit with PSD proteins (Foster et al., 2010) . Moreover, the NR2B subunit is also critical in the stabilization of calcium-calmodulin kinase II (CaMKII), with anchoring of this kinase to the NR2B subunit locking CaMKII in an active conformation, allowing it to continue to phosphorylate various proteins associated with NMDA-dependent synaptic plasticity (Lisman, Yasuda, & Raghavachari, 2012; Opazo et al., 2010; Sanhueza et al., 2011) .
While either of these mechanisms can be a possibility for why no translocation was observed in the hypothalamus, the directionality and effects of transcranial electrical stimulation on the brain remain largely unknown with the only results so far stemming from computational models Huang et al., 2017; Rahman, Lafon, & Bikson, 2015) , which are still being confirmed with in vivo results.
Phosphorylation of AMPA receptors in the hypothalamus
Similarly to the findings from the hippocampal samples, the phosphorylation of the S831 site was also observed in the hypothalamus. The GluA1 containing AMPA receptors are among the hypothalamus' most abundant type of glutamate receptors (Van Den Pol, HermansBorgmeyer, Hofer, Ghosh, & Heinemann, 1994) . This finding demonstrates that a key phosphorylation event, involved in the regulation of AMPA occurs within the hypothalamus (Hayashi et al., 2000; Lee et al., 2010) , a region on the base of the brain that was far from the site of the skull electrode. We do not know whether this change in the hypothalamus reflects a direct effect of current flow or whether this was an indirect effect caused by current flow in other areas. No significant changes were observed in the S845 site, similarly to the analysis of hippocampal samples.
tDCS duration and intensity
Our lab's previous findings show that in vivo tDCS at 250 μA for 30 min enhances LTP (Rohan et al., 2015) , while other studies in our laboratory show that intensities greater than 250 μA subjects can begin to show signs of tissue damage (Jackson et al., 2016) Taking this into consideration, along with other studies showing phosphorylation of AMPA receptors occurring 15 min after LTP induction, this intensity and time course chosen for this study seemed appropriate to address the proposed question. Further studies need to be conducted in order to further elucidate the effects of varying intensities and duration of tDCS on LTP, hippocampus, and the brain.
Conclusion
There is growing interest in the use of tDCS as a clinical tool due to its clinical benefits on neurological deficits and augmented human performance in memory, learning, or motor tasks. Our findings have shed light onto some of the neurobiological mechanisms by which tDCS could modulate brain function. We have shown that tDCS causes the translocation and phosphorylation of AMPA receptors in the hippocampus, a major center involved in memory and learning. This study adds to the body of literature that aims to unravel the mechanisms by which tDCS modulates synaptic plasticity by demonstrating that a single bout of tDCS induces the translocation and phosphorylation of AMPA receptors. Our findings on AMPA receptor modulation provide insight in to the neurobiological mechanisms by which tDCS can affect the brain.
Funding source
This work was supported by the Air Force Office of Scientific Research (AFOSR) grants (13RH14COR and 16RHCOR362).
